Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02372201
Other study ID # MicrobColonIrrFFG2013
Secondary ID
Status Completed
Phase N/A
First received January 12, 2015
Last updated February 25, 2015
Start date January 2013
Est. completion date October 2014

Study information

Verified date February 2015
Source University of Vienna
Contact n/a
Is FDA regulated No
Health authority Austria: Ethikkommission
Study type Interventional

Clinical Trial Summary

Consequences of Colon Hydrotherapy plus probiotic intervention on composition of GI microbiota and well being are analysed in subjects claiming GI inconveniences due to Irritable Bowel Syndrome or food intolerances.


Description:

Study objectives: Analysis of consequences of Hydro Colon Therapy plus probiotic intervention on GI microbiota and well being.

Study group: 78 subjects, inclusion criteria: 20-50yrs; under consultation at doctors or nutritionists because of claimed food inconveniences or Irritable Bowel Syndrome. exclusion criteria: antibiotics treatment and specified complex diseases.

Intervention: Hydro colon therapy 2- 5 washes within 3 weeks. probiotic intervention after end of Hydro colon therapy for 6 weeks ( DUOLAC® bacterial strains per capsule: Lactobacillus plantarum, Streptococcus thermophiles, Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium lactis, Bifidobacterium longum, and Bifidobacterium breve, fructooligosaccharides, 200 µg folic acid, 2.50 µg vitamin B12 and 55 µg selenium (all amounts corresponding to 100% of daily requirement). Control group: Vitamin B complex: 10µg cobalamin, 450µg folic acid, and 55 µg selenium.

Sample collection: standardized Feces collection, T1, before colon hydrotherapy, T2, immediately after colon hydrotherapy 2-5 washes of fasting ; T3, after six weeks of probiotic or Control intervention Analysis: standardizes food frequency questionnaire before and after intervention.

Feces analysis based on 16 S ribosomal DNA (rDNA) PCR DGGE and quantitative PCR (qPCR) and bioinformatic analysis.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date October 2014
Est. primary completion date June 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Subjects under consultation at doctors or nutritionists for Inflammatory Bowel Syndrome (IBD) of food intolerances

Exclusion Criteria:

- Pregnancy

- Antibiotic therapy 0,5 yrs before start

- Hormone therapies

- Malignant diseases

- Subjects were asked to avoid dietary supplements 4 weeks before and during the study.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Intervention

Other:
Hydro Colon Therapy plus probiotic
Probiotic intervention was done after 2-5 cycles of hydro colon therapy.

Locations

Country Name City State
Austria Dep. for Nutritional Sciences, University of Vienna Vienna Select your state

Sponsors (1)

Lead Sponsor Collaborator
University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary microbiota structure, using 16 S ribosomal based gradient electrophoresis ( DGGE) Microbiota were analysed for abundance of main microbiota groups and microbiota diversity using 16 S ribosomal based gradient electrophoresis ( DGGE). Abundance is shown in DNA copies/g feces; diversity as number of bands/ sample and by bioinformatic analysis 7- 8 weeks hydro colon washes plus probiotic No
Primary Gastrointestinal comfort, measured by Visual Analog Scale Gastrointestinal comfort was analysed by a standardised questionnaire. Pain was measured by Visual Analog Scale 7- 8 weeks hydro colon washes plus probiotic No
See also
  Status Clinical Trial Phase
Completed NCT03186872 - Improving Quality of Care With a Digital Behavioral Program in IBD Patient Centered Medical Home N/A
Completed NCT05640583 - Assessing Uniqueness of Inflammatory Bowel Disease Related Microbiome-derived Biomarkers N/A
Completed NCT04879810 - Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease N/A
Terminated NCT03220711 - Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon N/A
Completed NCT02026518 - Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel Syndrome Phase 4
Not yet recruiting NCT05542368 - Study of Thyroid Status in Patients With IBD